Eurobio Scientific S.A.
ALERS.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | €154,948 | €130,646 | €152,607 | €184,712 |
| % Growth | 18.6% | -14.4% | -17.4% | – |
| Cost of Goods Sold | €82,993 | €73,158 | €87,564 | €87,269 |
| Gross Profit | €71,955 | €57,488 | €65,043 | €97,443 |
| % Margin | 46.4% | 44% | 42.6% | 52.8% |
| R&D Expenses | €4,645 | €8,564 | €3,466 | €3,436 |
| G&A Expenses | €16,080 | €14,273 | €11,397 | €7,419 |
| SG&A Expenses | €45,458 | €33,522 | €31,000 | €24,499 |
| Sales & Mktg Exp. | €29,378 | €19,249 | €19,603 | €17,080 |
| Other Operating Expenses | -€104 | €5,261 | -€461 | -€2,479 |
| Operating Expenses | €49,999 | €47,347 | €34,005 | €25,456 |
| Operating Income | €13,400 | €10,141 | €30,869 | €71,987 |
| % Margin | 8.6% | 7.8% | 20.2% | 39% |
| Other Income/Exp. Net | €0 | -€3,164 | -€1,186 | €1,197 |
| Pre-Tax Income | €6,300 | €6,977 | €29,683 | €71,312 |
| Tax Expense | €2,300 | €2,142 | €4,746 | €10,768 |
| Net Income | €4,000 | €4,835 | €24,937 | €60,544 |
| % Margin | 2.6% | 3.7% | 16.3% | 32.8% |
| EPS | 0.39 | 0.43 | 2.2 | 5.58 |
| % Growth | -9.3% | -80.5% | -60.6% | – |
| EPS Diluted | 0.39 | 0.43 | 2.2 | 5.57 |
| Weighted Avg Shares Out | 10,249 | 11,153 | 10,224 | 10,848 |
| Weighted Avg Shares Out Dil | 10,249 | 11,217 | 10,257 | 10,876 |
| Supplemental Information | – | – | – | – |
| Interest Income | €2,781 | €1,118 | €43 | €412 |
| Interest Expense | €5,600 | €4,423 | €1,288 | €455 |
| Depreciation & Amortization | €8,400 | €13,145 | €9,521 | €7,865 |
| EBITDA | €20,400 | €24,545 | €40,492 | €79,632 |
| % Margin | 13.2% | 18.8% | 26.5% | 43.1% |